Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium-Reference-Cited by-同舟云学术

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

Published:2018-02-22 Issue:5 Volume:14 Page:1218-1229
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Willem Lander¹,Blommaert Adriaan¹,Hanquet Germaine²,Thiry Nancy²,Bilcke Joke¹,Theeten Heidi³,Verhaegen Jan⁴,Goossens Herman⁵,Beutels Philippe¹⁶

Affiliation:

1. Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium

2. Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium

3. Center for the Evaluation of Vaccination (CEV), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium

4. Department of Clinical Microbiology, Universitair Ziekenhuis Leuven, Leuven, Belgium

5. Laboratory of Medical Microbiology (LMM), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium

6. School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia

Funder

he Belgian Health Care Knowledge Centre (KCE)

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1428507

Reference40 articles.

1. Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

2. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review

3. Clinical and economic burden of community-acquired pneumonia among adults in Europe

4. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis

5. Early mortality in patients with community-acquired pneumonia: causes and risk factors

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates Matters;Value in Health;2023-12

2. Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature;Human Vaccines & Immunotherapeutics;2023-11-28

3. Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper;Revista Española de Quimioterapia;2023-02-08

4. Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study;Vaccine;2023-01

5. Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly;Vaccine;2022-11